Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
about
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem CellsBiological interplay between proteoglycans and their innate immune receptors in inflammationThe wound healing, chronic fibrosis, and cancer progression triadPathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumDevelopment of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation.Correlation of CD44v6 expression with ovarian cancer progression and recurrence.Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signalingChemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer.MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.The traditional Tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration.CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcomaA critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland.Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancerHyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.Expression and Function of CD44 in Epithelial Ovarian CarcinomaAn introduction to proteoglycans and their localizationProgesterone acts via the progesterone receptor to induce adamts proteases in ovarian cancer cells.Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2.CD44 is associated with the aggressive phenotype of nasopharyngeal carcinoma through redox regulationLumican and versican are associated with good outcome in stage II and III colon cancer.Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer.Mechanotransduction in cancer.Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation.Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis.Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.Isolation and characterization of stem-like cells from a human ovarian cancer cell line.Carcinoma origin dictates differential skewing of monocyte functionTumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapy.Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.
P2860
Q26853528-86C39544-EAA1-45A4-A5F3-D410FDEBB673Q27005610-5648E50E-560B-441B-B963-D692E7507A87Q27014616-A0A7BBD0-C202-4712-830A-8197223E23A9Q28073129-82EFA4CD-B7FD-437E-8678-5032ECEB104EQ30607164-A73AF808-27F4-45FD-AA1E-5805CCE9BFE4Q33361929-13CEA320-AFD9-4A5A-AE7F-319E68EEFB5CQ33844404-141954B9-5968-455B-B30C-89F87D43D70CQ34391763-291467D8-ABFA-4088-ACEC-BAE1BDF2F875Q34658867-667553A8-6788-4B3F-B19B-D2245B637D5FQ34886935-EBEEBCBC-3D47-4E17-83EB-D168198B4A51Q35017209-874CB01A-0B89-457C-A3DC-47D49D3D8AA7Q35032664-8D25DD17-A697-4863-B569-9C0240F2F1BAQ35089472-4B33BDDF-716C-4BF4-BB92-FEA5F120645BQ35116847-6A21A793-109A-4AC9-821A-1AB90A02E237Q35662679-E63AB1C9-D25C-4D09-B0E4-C0CBA5D9EDD3Q35746515-0FDF7203-A07F-4F5A-A026-BD4D4583DDB0Q35936614-6AE9EF96-DB7F-488A-867B-BF7D82E5AA5BQ36049170-A893A6E8-6892-41EE-B70E-B33128609BF5Q36094918-2EEFBC20-0BD4-4562-BE0F-7EC41288F90AQ36101228-E4EC00F6-6230-4310-8FB0-D9EC1742E5BEQ36280164-1A9CD83B-8495-4C0A-9FF5-6650EFDB0812Q36396500-C38E04A5-56CB-437A-8009-F37ADAC43BA7Q36409587-DE0ED510-34D4-44DE-BF29-D6ABAA2B13B2Q36481630-578B4F48-9661-4890-8B5D-14B317A7B5FBQ36616455-0949ABCD-5D95-4EC0-986F-83E685CA60C6Q36619090-431C3D48-E201-438A-BD8F-2717BE723A19Q37091797-3CEFF056-B44F-4218-9938-228575D74325Q37379954-E5F18FA7-CF50-432B-8421-EABC2E89BC02Q37631040-9E0DFB7F-02CA-43A0-A2B2-908734B3F495Q37716062-634D52CB-BD81-4F71-BFC2-C9D58DDFE4B6Q37720528-0405F85E-446F-4A04-BD56-E271575E64D0Q38172849-2503D663-AE23-4E92-B283-02BC448755AFQ38872768-07C200C5-94EB-47AB-8D79-9F21BE6A5BE3Q38889576-608A9FCD-84B9-40F5-BA65-DA80EE87EBDAQ38965047-663403D4-9544-455A-8A79-7BCFD53FD4FBQ39133222-36D8765F-1A58-4BA4-B68C-4F79A5C75149Q39429617-A445CCD5-DBE3-4615-9EBD-AD628C51E483Q41475462-CCED7113-935A-41E7-99BF-F4A8F3E924A7Q41672324-FA372F15-69B0-4A86-AED1-9A483F60D631Q46106579-937FC607-9B50-4CC1-B747-AFD1D15B60B4
P2860
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@ast
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@en
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@nl
type
label
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@ast
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@en
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@nl
prefLabel
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@ast
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@en
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
@nl
P2860
P921
P356
P1476
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis
@en
P2093
Martin K Oehler
P2860
P304
P356
10.3390/IJMS12021009
P407
P5008
P577
2011-01-31T00:00:00Z